Press Room

Intro text: 



For press inquiries about Breast International Group, its trials and research programmes, its member groups, its governance or its press releases, please contact : 


Press Releases


  • 14 July 2022: Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer | View EN press release
  • 16 March 2022: OlympiA trial - olaparib reduces risk of death by 32% in patients with a specific breast cancer profile | View EN press release | FR | NL
  • 4 February 2022: World Cancer Day 2022: the DECRESCENDO study | View EN press release | FR | NL


  • 7 December 2021: First results of MA.32 trial: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals 
    View EN press release
  • 16 September 2021: Metastatic breast cancer, an ultramarathon | View EN press release | FR | NL
  • 28 June 2021: First results of the European AURORA study: towards a better understanding of the molecular changes driving metastatic breast cancer | View EN press release | FR | NL
  • 16 June 2021: Breast International Group’s new Executive Board | View EN press release
  • 4 June 2021: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer | View EN press release
  • 3 June 2021: OlympiA adjuvant trial results show olaparib for BRCA 1/2 mutated and high-risk early breast cancer reduced recurrence risk by 42% | View EN press release
  • 4 February 2021: BIG and World Cancer Day - Together, all our actions matter | View EN press release | FR | NL


  • 9 December 2020: Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery | View EN press release | FR | NL | IT
  • 29 May 2020: Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib | View EN press release
  • 23 January 2020: Breast cancer prevention - significant progress: 49% reduction in breast cancer occurrence with anastrozole (long-term follow up results of the IBIS II Prevention trial) | View EN press release




  • 13 December 2017: Ovarian Suppression Reduces Recurrence for Young Breast Cancer Patients | Download press release EN
  • 7 December 2017: PANACEA study suggests immunotherapy may help to overcome trastuzumab-resistant breast cancer | Download press release EN
  • 8 September 2017: Primary results of LORELEI study presentedat ESMO 2017 Congress | Download press release EN
  • 5 June 2017: SOLE (Study of Letrozole Extension):A phase III randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer | Download press release EN
  • 5 June 2017:  APHINITY study shows Roche’s Perjeta®-based regimen reduced the risk of invasive cancer returning compared to Herceptin® and chemotherapy in HER2-positive early breast cancer | Download press release EN
  • 2 March 2017: Phase III APHINITY study shows Roche’s Perjeta® regimen helped people with an aggressive type of early breast cancer live longer without their disease returning compared to Herceptin® and chemotherapy | Download press release EN


  • 29 July 2016: New England Journal of Medicine” publishes results of MINDACT clinical trial 
    The 70-gene test (Mammaprint®) can significantly reduce use of chemotherapy among breast cancer patients and has the potential to change clinical practice: 46% of early stage breast cancer patients classified as high-risk by traditional methods can avoid chemotherapy | Download press release EN | ES | FR | NL 
  • 9 March 2016: Pfizer Awards Breast International Group (BIG) $1 Million Research Grant to Support Non‐Drug Related Breast Cancer Research | Download press release EN | DE | ES | FR | IT | NL


  • 10 December 2015: Belgian Dr. Martine Piccart has received prestigious international Brinker Award for Scientific Distinction in Clinical Research | Download press release EN | FR | NL 


  • 10 December 2014: Opening of international PANACEA study of patients with HER2+ breast cancer | Download press release 
  • 1 June 2014: ALTTO Test of Dual HER2 Blockade Finds Single Agent - Trastuzumab - Remains the Gold Standard | Download press release
  • 1 June 2014: New Treatment Option for Young Women with Hormone-Sensitive Breast Cancer | Download press release
  • 7 May 2014: AURORA, the first international molecular screening programme for metastatic breast cancer, presented at IMPAKT Breast Cancer Conference | Download press release



In the media

  • Cancer du sein: interview Martine Piccart (Télé Bruxelles, 15/01/2016) | View video (minute 08:25 to 15:25)
  • Borstkanker: oncologe Martine Piccart gehuldigd | Cancer du sein: l’oncologue Martine Piccart à l’honneur (Food in Action, 6 January 2016) | View article NL | FR
  • Prof. Martine Piccart: ‘Het onderzoek naar borstkanker bundelen en coördineren’ (News4Med, 18 December 2015) | View video NL | FR
  • Highlights of the EURECA Project (Enabling information re-Use by linking clinical Research and Care) | View video
  • The EURECA project - Building a better healthcare future through collaboration and technology (26 August 2015) | View article
  • The INTEGRATE project - Enabling data and knowledge sharing in biomedical research (27 Feb 2015) | View video
  • How can international collaboration benefit young researchers? (15 July 2014) | View video
  • A new metastatic breast cancer programme (19 June 2013) | View video 
  • ASCO: Dr. Martine Piccart, in Karnofsky Lecture, Outlines Vision for the Empowering of Academic Research (10 June 2013) CancerNetwork, Home of the Journal Oncology | View article
  • La princesse Mathilde plaide pour plus de recherches sur le cancer du sein (27 February 2013) | View article
  • Combattre le cancer sur tous les fronts. Le Vif Extra (17 November 2009)
  • Tailored treatments for breast cancer – TRANSBIG. In: Research for Europe. A selection of EU success stories, published by the EU Directorate-General for Research (2008)